 |
L-tyrosine-L-serine-L-leucine |
|---|---|
| Trade Name | Cms-024 |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2004-09-10 00:00:00 |
| Sponsor | CMS Peptides Patent Holding Company Limited;Unit 2106, 21st Floor, Island Place Tower, 510 King's Rd;North Point |
